BUDIGALIMAB

UNII: 6VDO4TY3OO
Preferred Substance Name: BUDIGALIMAB

2098225-93-3
ABBV181
ABBV-181
ANTI-PD1 MONOCLONAL ANTIBODY ABBV-181
BUDIGALIMAB [INN]
BUDIGALIMAB [USAN]
BUDIGALIMAB [WHO-DD]
IMMUNOGLOBULIN G1, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1), (HUMAN-MUS MUSCULUS MONOCLONAL PR-1648817 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL PR-1648817 .KAPPA.-CHAIN, DIMER
PR-1648817

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

BUDIGALIMAB

Synonyms and Mappings

Resources

Note